Breaking News Instant updates and real-time market news.

2016-10-13 11:48:00

PVCT

Provectus

$0.05

-0.0152 (-22.29%)

11:48

10/13/16

10/13

11:48

10/13/16

11:48

Provectus trading suspended due to 'abnormally' low price

NYSE MKT announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Provectus Biopharmaceuticals from the Exchange. Trading in the company's common stock on the NYSE MKT will be suspended immediately. NYSE Regulation has determined that the company is no longer suitable for listing pursuant to Section 1003 of the NYSE MKT Company Guide, due to the abnormally low trading price of its common stock.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.